Regenerative Medicine Program, Ottawa Hospital Research Program, Ottawa, Canada.
Cytotherapy. 2012 Feb;14(2):205-14. doi: 10.3109/14653249.2011.610302. Epub 2011 Sep 28.
Delayed neutrophil recovery following autologous hematopoietic stem cell transplantation (aHSCT) increases transplant-related morbidity. Apoptosis induced by cryopreservation and thawing of hematopoietic progenitor cells collected by apheresis (HPC-A) was investigated in this nested case-control study as a factor associated with delayed neutrophil recovery following aHSCT.
Among patients with lymphoma who underwent aHSCT between 2000 and 2007 (n = 326), 13 cases of primary delayed neutrophil recovery and 22 age- and sex-matched controls were identified. Apoptosis and viability were measured using multiparameter flow cytometry, and colony-forming capacity was determined using semi-solid methylcellulose assays.
HPC-A grafts from cases and controls had similar percentages of viable mononuclear cells (MNC) and CD34+ progenitor cells, as determined by standard 7AAD dye exclusion methods measured before and after cryopreservation. Patients with delayed neutrophil recovery received increased numbers of apoptotic MNC (P = 0.02) but similar numbers of apoptotic CD34+ cells per kilogram measured after thawing. Apoptosis was more pronounced in MNC compared with CD34+ cells after thawing, and apoptosis was negligible in freshly collected HPC-A products. Patients with delayed neutrophil recovery had fewer total colony-forming unites (CFU) and CFU-granulocyte-macrophages (GM) per 10(5) viable post-thaw MNC compared with controls (P < 0.05).
Increased numbers of apoptotic MNC in thawed HPC-A products are associated with delayed neutrophil recovery after aHSCT. Studies that address factors contributing to increased apoptosis are needed, and measuring apoptosis in thawed HPC-A may have a role in the assessment of graft adequacy.
自体造血干细胞移植(aHSCT)后中性粒细胞恢复延迟会增加与移植相关的发病率。本巢式病例对照研究调查了通过血细胞分离采集的造血祖细胞(HPC-A)在冷冻保存和解冻过程中诱导的细胞凋亡是否为 aHSCT 后中性粒细胞恢复延迟的相关因素。
2000 年至 2007 年间接受 aHSCT 的淋巴瘤患者(n=326)中,确定了 13 例原发性中性粒细胞恢复延迟病例和 22 例年龄和性别匹配的对照。使用多参数流式细胞术测量细胞凋亡和活力,并使用半固体甲基纤维素测定法确定集落形成能力。
通过标准的 7AAD 染料排除方法,在冷冻保存前后测量,病例和对照的 HPC-A 移植物中具有相似百分比的活单核细胞(MNC)和 CD34+祖细胞。接受延迟中性粒细胞恢复的患者接受了更多数量的凋亡 MNC(P=0.02),但解冻后每公斤接受的凋亡 CD34+细胞数量相似。解冻后 MNC 的凋亡比 CD34+细胞更为明显,新鲜采集的 HPC-A 产物中凋亡可忽略不计。与对照组相比,延迟中性粒细胞恢复患者的每 105 个解冻后活 MNC 中总集落形成单位(CFU)和 CFU-粒细胞-巨噬细胞(GM)数量较少(P<0.05)。
解冻的 HPC-A 产物中凋亡 MNC 的数量增加与 aHSCT 后中性粒细胞恢复延迟有关。需要研究导致凋亡增加的因素,并且测量解冻的 HPC-A 中的凋亡可能在评估移植物充足性方面具有作用。